In this episode of #ECDCOnAir, the discussion revolves around vaccination acceptance, exploring the factors influencing people's health choices, the role of social and behavioural sciences, the impact of misinformation, and the trends in vaccination rates across Europe. ECDC experts - Sarah Earnshaw Blomquist and Andrea Würz provide insights into how understanding these dynamics can help improve vaccination uptake and public health strategies. Learn more about the 5 C's here and join the ECDC Lighthouse . For more information about ECDC in general, visit ecdc.europa.eu or follow…
Apply by July 11, 2025, for the Annual Summer Training Course in Experimental Aging Research on Sep. 8-12, 2025, which will provide exposure to research programs in the experimental biology of aging.
Dr. Centor discusses concerns about proposals that nurse practitioners and physician assistants are interchangeable with primary care physicians with Dr. Christin Giordano McAuliffe.
As diagnoses of colorectal, breast, and other cancers continue to climb in people under age 50, researchers are trying to understand what’s behind this phenomenon. Is it environmental exposures, genetics, lifestyle? The culprits, they say, remain unclear.
Scientists have developed a test for use during brain cancer surgery that rapidly measures the levels of certain genetic mutations in patients’ tumor samples. The test uses droplet digital polymerase chain reaction technology and produces results within 15 minutes.
A device that measures the “stickiness” of cancer cells in tumor samples may help predict the likelihood of a patient’s cancer metastasizing. Researchers believe the device could eventually help doctors make more informed treatment choices.
FDA has approved the combination of the immunotherapy drugs ipilimumab (Yervoy) and nivolumab (Opdivo) for the initial treatment of people with advanced colorectal cancer whose tumors are classified as MSI-H or dMMR.
In this episode of ECDC: On Air, Maria Keramarou, ECDC's expert in vaccine-preventable diseases, discusses the rising cases of measles in Europe. We explore the highly contagious nature of measles, the importance of vaccination, the resurgence of cases post-COVID, and the challenges of vaccine hesitancy and misinformation. Learn more about the European Immunization Week on our dedicated page here . Find all the information about vaccinations in YOUR language on the European Vaccination Information Portal . For more information about ECDC in general, visit https://ecdc.europa.eu…
Buprenorphine for opioid use disorder (1:30), triptans for acute migraine (5:30), premenstrual syndrome (6:50), pain management for IUD insertion (11:00), liver fibrosis stage in chronic hepatitis C infection (12:30), and cold water immersion for muscle soreness (14:30).
NIA investigators have created a biological clock for mice based on blood measurements. Learn how the clock can help predict differences in aging and how the findings could translate to clinical practice.
A subgroup of mesenchymal stem cells, called high-risk MSCs, appears to fuel the formation of cancerous lesions in the fallopian tubes and the lesions’ transition to ovarian cancer, a study has found.
In this episode, we explore Europe's progress toward the 2030 SDGs with Charlotte Deogan, expert in communicable diseases at ECDC. This episode unpacks SDG Target 3.3, which aims to end the epidemics of HIV/AIDS and tuberculosis, and combat viral hepatitis and sexually transmitted infections by 2030. As ECDC releases its first comprehensive monitoring report on the SDGs, we discuss the EU/EEA's current status and whether we are on track. ECDC’s reports and other work on the SDGs can be found here . For more information about ECDC in general, visit https://ecdc.europa.eu or…
In small trials, personalized treatment vaccines appeared to prevent cancer from returning in patients who had successful surgery to remove their tumors. The treatments, which were created based on intensive analyses of patients’ tumors, appeared to be safe.
Labor management (1:30), acute migraine headache (4:00), tirzepatide for sleep apnea (8:20), options for unintended pregnancy (11:20), artificial intelligence scribes (15:00), and testosterone replacement in men with sexual dysfunction (16:50).
Documented conversations on goals of care are uncommon in AYA patients with advanced cancer. Researchers found that many patients did not have these discussions until the last month of life, and many asked about palliative care.
Some cancers come back many years after successful treatment, often as metastatic disease. Researchers believe if and how this happens is heavily influenced by dormant cancer cells and their interaction with the immune system.
Plexin-B1 shapes glial networks around beta-amyloid plaques. An NIA-funded study has found that targeting it may improve plaque clearance and reduce brain inflammation.
A new drug targeting synaptic resilience shows potential in treating Alzheimer’s disease in an NIA-funded study, with early trials indicating safety and possible brain damage reduction. Further research is needed on the drug’s long-term effects.
How can diabetes health care professionals work with cardiologists to treat cardiovascular disease in people with diabetes? Learn more about managing heart disease and heart failure with lifestyle changes and medicines.